The PE Ratio as of December 2025 (TTM) for Orient EuroPharma Co., Ltd. (4120.TWO) is -8.41

According to Orient EuroPharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -8.41. This represents a change of -159.44% compared to the average of 14.15 of the last 4 quarters.

Orient EuroPharma Co., Ltd. (4120.TWO) Historical PE Ratio (quarterly & annually)

How has 4120.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Orient EuroPharma Co., Ltd. over the last ten years is 10.89. The current -8.41 PE Ratio has changed -7820.73% with respect to the historical average. Over the past ten years (40 quarters), 4120.TWO's PE Ratio was at its highest in in the September 2024 quarter at 97.31. The PE Ratio was at its lowest in in the September 2023 quarter at -26.69.

Orient EuroPharma Co., Ltd. (4120.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Orient EuroPharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orient EuroPharma Co., Ltd. (4120.TWO) Average PE Ratio

How has 4120.TWO PE Ratio performed in the past?

The current PE Ratio of Orient EuroPharma Co., Ltd. (4120.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Orient EuroPharma Co., Ltd. (4120.TWO) PE Ratio vs. Peers

How is 4120.TWO’s PE Ratio compared to its peers?

Orient EuroPharma Co., Ltd.’s PE Ratio is greater than Senhwa Biosciences, Inc. (-12.86), greater than Energenesis Biomedical CO.,LTD. (-13.33), greater than Formosa Pharmaceuticals, Inc. (-69.31), greater than BRIM Biotechnology, Inc. (-15.95), greater than AnnJi (-13.55), greater than Medigen Biotechnology Corp. (-68.66), less than Nang Kuang Pharmaceutical Co., Ltd. (14.49), greater than Bionime Corporation (-34.77), greater than TWi Biotechnology, Inc. (-10.75), less than Maxigen Biotech Inc. (18.87),

Build a custom stock screener for Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient EuroPharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orient EuroPharma Co., Ltd. (4120.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orient EuroPharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.